エビリファイは少量で抗うつ薬、高用量で抗精神病薬として作用するが、CBDも同じD2パーシャルアゴニストなので抗うつ薬として使用するには少量の方がいい。 https://t.co/mbN8MB00eq
pic ref. Figure 3 Int J Mol Sci. 2019 Jul; 20(13): 3314. ref. https://t.co/OOpj7H2Yav https://t.co/JYorkuFGYk
@USATODAY @dunkindonuts pm me i have ideas on how to reduce murders by cops dramatically https://t.co/nxe6lWm8Mm
@Peter_Grinspoon Don’t forget this one from the guy who discovered d2 receptors. https://t.co/2u06WSd55o
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. https://t.co/0NDrXooIiE #CBD #hemp #cannabidiol
カンナビジオールは、ドーパミンD2High受容体の部分アゴニストであり、その抗精神病薬の臨床用量を予測します。 https://t.co/Qx5XdW0m2v https://t.co/0NDrXo77r6 #ヘンプ論文 #統合失調症
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/MRwJNsooxu
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose... https://t.co/O3t4k9sbUU
RT @ILMCPP: Recent reports showed that cannabidiol alleviated the signs and symptoms of schizophrenia. https://t.co/FSYASBX1WG
Recent reports showed that cannabidiol alleviated the signs and symptoms of schizophrenia. https://t.co/FSYASBX1WG
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose #CBD $GWPH https://t.co/TLt9rySHDc
Very important facts about CBD to treat Schizophrenia and why it is so antipsychotic:... https://t.co/Ht0PKo7Kzy
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/4kKu0mPnsb
RT @DrJKhokhar: Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/BfyW…
RT @DrJKhokhar: Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/BfyW…
RT @DrJKhokhar: Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/BfyW…
RT @DrJKhokhar: Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/BfyW…
RT @DrJKhokhar: Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/BfyW…
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/BfyW6sC3Mm
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/GxICMOBn19
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. @NCBI https://t.co/Lm0OvBPjPX
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://t.co/AqIc9P3ZqW